Catalyst Wire Dossier Catalyst Wire Dossier

Naltrexone SR/Bupropion SR Trilayer Tablet

naltrexone sustained-release with bupropion sustained-release combination tablet · Orexigen Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Naltrexone SR/Bupropion SR Trilayer Tablet, covering 2014-12-11 to 2014-12-11. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers [Phase 1]

See pricing